Cyclohexylacetyl-Phe-Arg-Ser-Val-Gln-NH2 trifluoroacetate salt

Suppliers

Names

[ CAS No. ]:
113584-01-3

[ Name ]:
Cyclohexylacetyl-Phe-Arg-Ser-Val-Gln-NH2 trifluoroacetate salt

[Synonym ]:
kallikrein inhibitor peptide
kki-7
cyclohexylacetyl-phe-arg-ser-val-gln amide

Chemical & Physical Properties

[ Density]:
1.39g/cm3

[ Molecular Formula ]:
C36H58N10O8

[ Molecular Weight ]:
758.90800

[ Exact Mass ]:
758.44400

[ PSA ]:
313.81000

[ LogP ]:
2.83190

[ Index of Refraction ]:
1.637

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Articles

In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides.

Adv. Exp. Med. Biol. 247B , 23-28, (1989)

Kininogen sequence analogs containing amino acid residues around the Arg-Ser cleavage site of bovine kininogens were prepared with bulky aliphatic residues in P3 position. KKI-7 (containing a cyclohex...

The design of specific inhibitors of tissue kallikrein and their effect on the blood pressure of the rat.

Adv. Exp. Med. Biol. 247B , 9-13, (1989)

Prolonged kallikrein inhibition does not affect the basal growth and secretory capacity of rat adrenal cortex, but enhances mineralo- and glucocorticoid response to ACTH and handling stress.

Histol. Histopathol. 15(2) , 441-4, (2000)

The effects on the pituitary-adrenocortical functions of the prolonged (7-day) blockade of endogenous bradykinin (BK) synthesis, obtained by the administration of the kallikrein inhibitor (K-I) cycloh...


More Articles


Related Compounds

  • 4-(1H-1,2,3,4-tetrazol-5-yl)butan-1-ol
  • N-{[(1R,2S,6R,7S)-3,5-dioxo-4,10-dioxatricyclo[5.2.1.0^{2,6}]decan-1-yl]methyl}-2,2-dimethylpropanamide
  • 2-[2-(N-methyl-2-phenylethenesulfonamido)acetamido]-N-(3-methylphenyl)benzamide
  • 2-methyl-1-(1H-1,2,4-triazol-3-yl)propan-2-ol
  • [(1-Cyano-1,2-dimethylpropyl)carbamoyl]methyl 2-[(2,6-dichlorophenyl)sulfanyl]acetate
  • N-[2-(4-chlorophenyl)ethyl]-3-hydroxyadamantane-1-carboxamide
  • 2-(3-(3-bromophenyl)propoxy)tetrahydro-2H-pyran
  • 2'-(N-t-Butylsulfamoyl)-4-methylbiphenyl
  • Ethyl 6-benzyl-2-oxo-1,2,5,6,7,8-hexahydro-1,6-naphthyridine-3-carboxylate
  • Ethyl 2-oxo-1,2,5,6,7,8-hexahydro-1,6-naphthyridine-3-carboxylate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.